MEDIUM
CVE-2012-4506
CWE-22Published: October 22, 2012· Updated: Jun 16, 2026
4.6
CVSS v3.1
Official Description
Directory traversal vulnerability in gitolite 3.x before 3.1, when wild card repositories and a pattern matching "../" are enabled, allows remote authenticated users to create arbitrary repositories and possibly perform other actions via a .. (dot dot) in a repository name.
Technical Analysis
CVE-2012-4506 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.
Exploitation requires some privileges, which limits the exposure to scenarios where an attacker has already gained initial access.
CVSS v3.1 Vector Breakdown
Exploitability
Attack VectorNetwork
Attack ComplexityHigh
Privileges Req.
User Interaction
Scope
Impact
ConfidentialityP
IntegrityP
AvailabilityP
AV:N/AC:H/Au:S/C:P/I:P/A:P
Affected Vendors & Products
gitolite1 product(s)
gitolite
sitaram_chamarty1 product(s)
gitolite
Source: NVD CPE · 5 total CPE entries
Exploit & PoC Resources
NO KNOWN EXPLOITNo public exploit confirmed at this time
Exploit-DB
Offensive Security exploit database
GitHub PoC Search
Community PoC repositories
Rapid7 / Metasploit
Metasploit module search
PacketStorm
Security advisories & exploits
NVD Detail
Official NIST entry
MITRE CVE
CVE Program entry
External links open in a new tab. Always verify in a controlled environment before use.
Official Patches & Advisories
All References (14)
→
http://secunia.com/advisories/50896Vendor Advisory
→
http://secunia.com/advisories/50896Vendor Advisory
Quick Facts
CVE IDCVE-2012-4506
CVSS Score4.6 / 10
SeverityMEDIUM
WeaknessCWE-22
CISA KEVNo
Affected2 vendor(s)
PublishedOct 22, 2012
Related CVEs (CWE-22)
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2012-4506 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWatch. CVE data is provided under the NVD usage policy.